logo
Earnouts Can Be The Best Way To Buy A Business

Earnouts Can Be The Best Way To Buy A Business

Forbes06-07-2025
A core fundamental to evaluating whether to buy a certain business is the assurance, to the best of the buyer's ability, that the business' performance will remain status quo post sale assuming no catastrophic events. While potential future growth is sexy, stability is valuable.
Earnouts, also referred to as performance-based conditions, can be an ideal way to bridge the gap between buyers and sellers and address issues that can drastically impact the value of a business post sale, either up or down. These deal terms provide the seller with the ability to earn (this the term 'earnout') the full valuation if certain targets are hit in the future and provide the buyer with protection if they don't.
Some examples of scenarios where earnouts should be considered include:Keep It Simple
Earnouts are best laid out when the conditions are clear and easily measured such as achieving specific revenue targets or retaining a certain customer after the sale.
To effectively structure an earnout, two valuations need to be compiled. The first is based on the status quo financials. The second is based on the scenario whereby whatever is measured actually happens. The delta becomes the earnout target. For example, a business generates $1.0 million in earnings and the buyer and seller agree on a 5x multiple and thus a $5.0 million purchase price. However, one customer represents 30% of the revenues and profits. As such, if that client stops buying, the profits will drop to $700,000 and the enterprise value at the same multiple will be $3.5 million. The difference, or delta of $1.5 million becomes the earnout piece. As such, the deal structure would be a $3.5 million purchase price and the opportunity for the seller to earn an additional $1.5 million if the customer continues to buy from the new owner.
The same structure can be used for the other examples noted herein. The key is to establish two valuations with the situation happening or not happening.
The word earnout on a a keyboard keySellers Cannot Guarantee A Buyer's Success
While this all sounds great from a buyer's perspective to protect their downside, the seller will have legitimate concerns. Although the buyer assumes the greater risk in these transactions, a seller cannot guarantee their success. What if the client stops buying because the new owner is incompetent? This is no fault of the seller, and they should not be penalized for it.
Conversely, where earnouts are warranted, the buyer only has the word of the seller and whatever research they have been able to compile, that certain events will or will not materialize. As such, there must be transparent and meaningful discussions between the sides to understand the level and potential impact of these concerns.
How Long Should The Measurement Period Be?
In most cases, there is a disparity between buyer and seller positions in the earnout measurement period. As a guideline, it is reasonable in most cases for this to be somewhere between 12-24 months after closing the deal.
In cases where the seller may have implemented certain initiatives that will only generate revenue after the sale and they want that factored into the valuation, it may take a longer period for those events to materialize.
In situations where the business has experienced a recent downturn, a buyer will want a shorter measurement period because if they are able to turn things around, why should the seller benefit from what they, the buyer, has done to turn things around?
All Or Nothing Doesn't Make Sense
Earnouts, in most cases, are most acceptable and fair to both sides when there is a sliding scale in place as a measurement tool. Meaning, the condition can be partially met and thus partially paid. If the earnout piece is $1.0 million and once measured it is 80 percent achieved, then 80 percent of the earnout can be paid. The suggestion is also to have a floor so there's a point at which the earnout is not paid if the metric is for example, below a certain percentage.
Know Your Lender – Earnouts May Not be Allowed
Many lenders will not fund deals where there is an earnout unless the maximum potential earnout amount is factored into their underwriting. They will not agree to an amount of leverage and debt service if the business may be faced with a future additional expense from an earnout. The best way to address this is to carve out a seller not equal to the total potential earnout that is subject to adjustment if the target is not met. Or, via the seller retaining equity in the business post sale that can be diluted based upon the results of the earnout's measurement.
A Final Word
Performance-based conditions can be an effective way to get deals to the finish line. While buyers always want to mitigate their deal risk, they must also understand that these deal terms only make sense when there is the possibility of a significant event attributable to the former owner impacting the business after the sale. Similarly, a seller must realize that a business remaining at least status quo post sale is a fundamental requirement for any prospective buyer and therefore the selling party must have flexibility and assume part of the risk if they are delivering a business that they know can change significantly in the near future and by no fault of the buyer.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Option Care Health, Inc. (OPCH): A Bull Case Theory
Option Care Health, Inc. (OPCH): A Bull Case Theory

Yahoo

time20 minutes ago

  • Yahoo

Option Care Health, Inc. (OPCH): A Bull Case Theory

We came across a bullish thesis on Option Care Health, Inc. on Brian's Substack by Brian Flasker. In this article, we will summarize the bulls' thesis on OPCH. Option Care Health, Inc.'s share was trading at $29.35 as of July 31st. OPCH's trailing and forward P/E were 23.29 and 19.65, respectively according to Yahoo Finance. A home infusion nurse in full PPE gown delivering treatments to a patient in their own home. Option Care Health (OPCH) has evolved into the dominant independent provider of home and alternate site infusion services in the U.S., originating from Madison Dearborn Partners' 2015 acquisition of Walgreens Infusion Services. The 2019 reverse merger with BioScrip and full divestiture by Walgreens and MDP by 2023 paved the way for OPCH to operate with full independence. Led by CEO John Rademacher and CFO Michael Shapiro, both with substantial equity stakes, OPCH has built a national infrastructure of 91 pharmacies and 99 infusion suites, covering 96% of the U.S. population. The company's integrated model provides cost-effective, high-quality infusion therapies in outpatient and home settings, capitalizing on a healthcare trend shifting treatments away from costly hospitals. This platform serves over 1,400 contracts with 800+ partners, including all top 10 national insurers. Acute therapies, though operationally complex, act as a competitive wedge, while chronic therapies anchor long-term recurring revenues. OPCH's mix—75% chronic, 25% acute—combined with a focus on generics and biosimilars, ensures resilience against pricing volatility. With its Advanced Practitioner (AP) model, OPCH is pushing clinical boundaries, managing more complex therapies in lower-cost settings and enhancing utilization of its already-built infrastructure. Only ~50% of its infusion suite capacity is currently utilized, leaving ample runway for capital-light growth. Despite industry concerns like drug pricing reforms and labor shortages, OPCH's embedded relationships, clinical capabilities, and scalable model offer strong visibility into cash flow and earnings. Trading at ~15.4x 2025 owner earnings with a 17.4% expected IRR, OPCH represents a high-quality compounder with an entrenched moat and significant upside. Previously, we covered a bullish thesis on Chemed Corporation by 310 Value in April 2025, which highlighted the durability of its earnings, temporary volatility in its subsidiaries, and disciplined share repurchases. The company's stock price has depreciated by approximately 29% since our coverage. This is because temporary segment headwinds persisted longer than expected. The thesis still stands as Chemed's core fundamentals remain intact. Brian Flasker shares a similar view but emphasizes OPCH's capital-light model and payer-aligned infrastructure. Option Care Health, Inc. is not on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 40 hedge fund portfolios held OPCH at the end of the first quarter, which was 40 in the previous quarter. While we acknowledge the potential of OPCH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Steel Dynamics, Inc. (STLD): A Bull Case Theory
Steel Dynamics, Inc. (STLD): A Bull Case Theory

Yahoo

time20 minutes ago

  • Yahoo

Steel Dynamics, Inc. (STLD): A Bull Case Theory

We came across a bullish thesis on Steel Dynamics, Inc. on Stock Picker's Journey's Substack by Gregg Jahnke. In this article, we will summarize the bulls' thesis on STLD. Steel Dynamics, Inc. 's share was trading at $127.56 as of July 31st. STLD's trailing and forward P/E were 18.51 and 14.29 respectively according to Yahoo Finance. Steel Dynamics (STLD) has been added to the Model 25 portfolio at $131, replacing AES, in a rare top-down decision driven by macroeconomic expectations rather than valuation. While the author typically favors bottom-up stock picks like Pepsi and Gentex, which were purchased at near-decade lows, the potential passage of the BBBill and a possible economic surge in 2026 prompted this more thematic move. STLD stands to benefit from pro-growth industrial policies, and with momentum shifting in favor of the bill's passage, exposure to a high-quality cyclical stock became desirable. A standout first-quarter earnings call reinforced conviction, as STLD's aggressive capital expenditure plans—particularly its efforts to reshape the aluminum industry—signal long-term vision. Notably, the company has repurchased 40% of its stock over the past decade and maintains a clean balance sheet, having recently refinanced debt with manageable near-term maturities. Although other aluminum plays like Century, Alcoa, and Kaiser were considered, STLD was viewed as superior, even compared to Nucor (NUE), due to its aluminum exposure. Wall Street's focus on short-term earnings has led to a misunderstanding of STLD's strategic positioning, as highlighted by analyst John Tumazos's incisive questioning on the Q1 call. The company's spread-based model in scrap steel and aluminum is seen as lower risk than perceived, with significant upside potential. Strong institutional support from Victory Capital, Norges Bank, and T. Rowe Price adds credibility to the investment. Though STLD has underperformed recently and issued a soft Q2 outlook, the long-term case for its role in rebuilding U.S. manufacturing justifies the timing of this buy. Previously, we covered a on Steel Dynamics, Inc. (STLD) by Gregg Jahnke in February 2025, which highlighted the company's capital discipline, low-cost structure, and long-term potential. The company's stock price has depreciated approximately by 4% since our coverage due to near-term macro headwinds. Gregg Jahnke shares a similar view but emphasizes a top-down, policy-driven case based on expected 2026 growth. Steel Dynamics, Inc. is not on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 45 hedge fund portfolios held STLD at the end of the first quarter which was 45 in the previous quarter. While we acknowledge the potential of STLD as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Snap-on Incorporated (SNA): A Bull Case Theory
Snap-on Incorporated (SNA): A Bull Case Theory

Yahoo

time20 minutes ago

  • Yahoo

Snap-on Incorporated (SNA): A Bull Case Theory

We came across a bullish thesis on Snap-on Incorporated on The Reservist's Substack by Yehoshua Zlotogorski. In this article, we will summarize the bulls' thesis on SNA. Snap-on Incorporated's share was trading at $321.19 as of July 31st. SNA's trailing and forward P/E were 17.11 and 17.24, respectively according to Yahoo Finance. An engineer at a workbench surrounded by automotive parts, tools, and microchips. Snap-On's latest earnings report reinforces the author's conviction in a trade built on a favorable risk/reward setup. The position, entered with a tight downside near $300 (a 3% loss), is based on Snap-On's strong fundamentals and dominant market position, which help anchor valuation. The key bullish thesis is that the post-pandemic lull in tool and equipment purchases—now entering its final stages- will fade by late 2025 into 2026, setting up for a cyclical rebound. This quarter supports that view: the Tools Group returned to growth (+1.7%) after four quarters of decline, RS&I also expanded, and while C&I fell 8%, the drop was attributed largely to temporary effects, with a recovery seen as the quarter progressed. Management continues to deflect with macro and geopolitical explanations, but the author sees the stagnation as a result of pandemic-era pull-forward, supported by weak financing data for big-ticket items. As these loans roll off over their typical four-year cycles, demand should return. The author also sees Snap-On as a likely beneficiary of tariff relief and potential industrial spending from the so-called 'Big Beautiful bill,' both of which could drive relative outperformance. Meanwhile, margins remain strong, cash builds, buybacks persist, and the 2.75% dividend provides a steady return while awaiting the upturn. The stock could rise 30% back to its historical $370–390 range, with minimal downside. Sized at 4% of the portfolio, the position provides lower beta industrial exposure while retaining the upside target common across the author's broader trading strategy. Further adds are possible on dips near $300. Previously, we covered a on Snap-on Incorporated (SNA) by William Fleming-Daniels in November 2024, which highlighted strong margins, stable cash flow, and long-term growth. The company's stock has depreciated ~11% since our coverage, as the thesis hasn't played out yet. Yehoshua Zlotogorski shares a similar view but emphasizes a near-term cyclical rebound driven by financing roll-offs. Snap-on Incorporated is not on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 36 hedge fund portfolios held SNA at the end of the first quarter which was 32 in the previous quarter. While we acknowledge the potential of SNA as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store